SPECIALTIES / ORTHO/sPORTS MED

CryoText for Orthopedic & Sports Medicine Applications

Whether addressing damaged tissue in the articular cartilage of the knee, hip, shoulder, or surrounding soft tissue, consider Wharton’s jelly for Connective Tissue Supplementation to repair or replace the damaged tissue with new healthy connective tissue.

JAKE BALLARD

FORMER NEW YORK GIANTS
TIGHT END

ROY JONES

FORMER WORLD CHAMPION & US OLYMPIAN BOXER

BRET SABERHAGEN

3x ALL-star, world series 2x al cy young award baseball pitcher

WHARTON’S JELLY ALLOGRAFT

Wharton’s jelly (WJ) allografts consist of human umbilical cord tissue that is disassociated, suspended in saline, and cryopreserved. Their primary function is to provide cushioning and structural support and replace missing or damaged tissue in the patient, applied directly to the defect or injured area in soft tissues. They are applied via syringe and are typically used in ligament, muscle, or cartilage tears.

Ongoing Retrospective Repository Data

Data Collection Protocol Approved by the Institute of Regenerative and Cellular Medicine (IRB)

KNEES

improvements in nprs and womac

Knee Data ranges chart

Knee Data ranges table

This data is based on a sample of 178 patients with structural knee defects from 29 clinics enrolled in our observational study. There are 82 males and 96 females, aged 54 to 92. Ninety days after the Wharton’s jelly application, patients reported a 32% improvement in NPRS (current pain) and a 33% overall WOMAC improvement (pain/ stiffness/ function). The progress shown is from only one application, although most care providers apply two Wharton’s jelly allografts for this area.

Hips

improvements in nprs and womac

hips Data ranges chart

Hips Data ranges chart

This data is based on a sample of 78 patients with structural hip defects from 19 different clinics enrolled in our observational study. There are 45 males and 33 females, aged 30 to 91. Ninety days after the Wharton’s jelly application, patients reported a 40% improvement in NPRS (current pain) and a 23% overall WOMAC improvement (pain/ stiffness/ function). The progress shown is from only one application, although most care providers apply two Wharton’s jelly allografts for this area.

SHOULDERS

improvements in nprs and womac

Shoulder Data ranges chart

Shoulders Data ranges chart

This data is based on a sample of 143 patients with structural shoulder defects from 38 different clinics enrolled in our observational study. There are 80 males and 63 females, aged 36 to 89. Ninety days after the Wharton’s jelly application, patients reported a 39% improvement in NPRS (current pain) and a 35% overall WOMAC improvement (pain/ stiffness/ function). The progress shown is from only one application, although most care providers apply two Wharton’s jelly allografts for this area.

CODE LIST

Download the ICD-10 Code List to Identify Other Potential Use Sites.

Download Here

CryoText Product Information

For more information about our Cryotext product, visit the link below.

Pricing and PLACING AN order

For pricing or to place an order, login or setup an account to get immediate access to our MEDNGINE platform.

DON’t HESITATE TO REACH OUT.

If you have any further questions, please contact us. We look forward to speaking with you!